
Technology
India must balance energy needs with climate adaptation, says US scientist
By Katherine Langford
Advertisement · Why this ad?

The DCGI has sought the cancellation of manufacturing licences for obeticholic acid (5mg and 10mg tablets), used to treat primary biliary cholangitis (PBC), following similar actions by the US FDA and the European Medicines Agency.
Bangalore
Technology
Saturday, November 14, 2026
1 min